[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630385":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":10,"responsibleParty":29,"collaborators":10,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":33,"sex":38,"minAge":39,"maxAge":40,"enrollmentInfo":41,"targetDuration":10,"studyType":44,"phases":10,"briefSummary":45,"conditions":46,"keywords":10,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":10},{"fullName":5,"class":6},"Ottawa Heart Institute Research Corporation","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Evaluation",null,"This is a non-randomized study following individuals in perimenopause with type 2 diabetes. The population will follow a 4 evaluation\u002Fobservation period with associated questionnaires and medical exams, including bloodwork and cardiac echo.",[13],"Other: 4 years of clinical evaluations.",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"4 years of clinical evaluations.","The intervention in this study is the additional clinical evaluations for women with type 2 DM and in perimenopause.",[9],[20],{"name":21,"affiliation":5,"role":22},"Kerri Anne Mullen, Ph.D.","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Carolyn Van Dam","CONTACT","613-696-7000","CVandam@ottawaheart.ca",{"type":30,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100630385","endocrine-disruption-menopause-and-poor-sleep-in-women-with-type-2-diabetes-effects-on-cardiovascular-health-100630385",false,"NCT07486986","Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health","EMPOWER","Inclusion Criteria:\n\n* Female Sex\n* Age range 48-58 years\n* In menopausal transition phase (pre-menopause or peri-menopause)\n* Diagnosis of Type 2 Diabetes Mellitus\n* Have access to and regularly use a smartphone with internet access\n\nExclusion Criteria:\n\n* Male Sex\n* Currently Pregnant\n* Prior history of total hysterectomy or bilateral oophorectomy\n* Prior diagnosis of any of the following:\n\nCoronary Vascular Disease (CVD) including coronary heart disease, heart failure, congenital heart disease stroke\u002Ftransient ischemic attack, valvular heart disease, peripheral vascular disease, aortapathy, atrial fibrillation or flutter, other CVD.\n\n\\- Untreated serious mental illness (e.g, untreated psychosis).","FEMALE","48 Years","58 Years",{"count":42,"type":43},381,"ESTIMATED","OBSERVATIONAL","EMPOWER aims to determine the overall effect of menopause and sleep disruption on cardiac remodeling in women with type 2 diabetes.",[47,48,49],"Menopause","Sleep Disruption","T2DM","NOT_YET_RECRUITING","2026-06-30",{"date":53,"type":54},"2026-07-01","ACTUAL",{"date":56,"type":43},"2026-09",{"date":58,"type":43},"2032-12",{"name":5,"class":6}]